New glaucoma medications
There are several new glaucoma medications that have been approved or are in development. Here are a few examples:
- Roclanda (netarsudil): Approved in 2017, Roclanda is a once-daily eye drop that is used to treat open-angle glaucoma and ocular hypertension. It works by reducing the production of aqueous humor, which is the fluid that flows through the eye and can increase pressure.
- Xelpros (latanoprostene bunod): Approved in 2017, Xelpros is a once-daily eye drop that is used to treat open-angle glaucoma and ocular hypertension. It works by reducing the production of aqueous humor and increasing the outflow of the fluid from the eye.
- Vyzulta (latanoprostene bunod): Approved in 2017, Vyzulta is a once-daily eye drop that is used to treat open-angle glaucoma and ocular hypertension. It works by reducing the production of aqueous humor and increasing the outflow of the fluid from the eye.
- Rhopressa (netarsudil): Approved in 2017, Rhopressa is a once-daily eye drop that is used to treat open-angle glaucoma and ocular hypertension. It works by reducing the production of aqueous humor and increasing the outflow of the fluid from the eye.
- Rocklatan (netarsudil and latanoprost): Approved in 2020, Rocklatan is a once-daily eye drop that is used to treat open-angle glaucoma and ocular hypertension. It works by reducing the production of aqueous humor and increasing the outflow of the fluid from the eye.
- Aerie Pharmaceuticals' AR-13503: This is a new medication that is being developed to treat glaucoma. It works by reducing the production of aqueous humor and increasing the outflow of the fluid from the eye.
- KPI-121 1.0%: This is a new medication that is being developed to treat glaucoma. It works by reducing the production of aqueous humor and increasing the outflow of the fluid from the eye.
- Bimatoprost 0.03%: This is a new medication that is being developed to treat glaucoma. It works by reducing the production of aqueous humor and increasing the outflow of the fluid from the eye.
- Latanoprost 0.005%: This is a new medication that is being developed to treat glaucoma. It works by reducing the production of aqueous humor and increasing the outflow of the fluid from the eye.
- Brimonidine 0.2%: This is a new medication that is being developed to treat glaucoma. It works by reducing the production of aqueous humor and increasing the outflow of the fluid from the eye.
It's important to note that these medications are still in the development stage and have not yet been approved by regulatory agencies. Additionally, the effectiveness and safety of these medications have not yet been fully established.